NCT03290248View on ClinicalTrials.gov

Study to Assess the Safety, Tolerability, and Preliminary Efficacy of B244 in Healthy Volunteers and Subjects With Seasonal Allergic Rhinitis

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

71

Participants

Timeline

Start Date

September 19, 2017

Primary Completion Date

December 21, 2018

Study Completion Date

December 21, 2018

Conditions
Allergic RhinitisAllergic Rhinitis Due to Grass PollenHealthy Volunteers
Interventions
BIOLOGICAL

B244 suspension

B244 suspension in 30ml/bottle

BIOLOGICAL

Vehicle

Vehicle, 30ml/bottle

Trial Locations (2)

92780

Orange County Research Center, Tustin

M6G 3V1

Inflamax, Mississauga

Sponsors

Lead Sponsor

AOBiome LLC
All Listed Sponsors
collaborator

Orange County Research Center

OTHER

collaborator

Integrium

INDUSTRY

lead

AOBiome LLC

INDUSTRY